Have a personal or library account? Click to login
Difficulties in Treatment of Iridocorneal Endothelial Syndrome - Case Report Cover

Difficulties in Treatment of Iridocorneal Endothelial Syndrome - Case Report

Open Access
|Jul 2022

References

  1. 1. Li F, Liu Y, Sun Y, Zhang X. Etiological mechanism of iridocorneal endothelial (ICE) syndrome may involve infection of herpes simplex virus (HSV) and integration of viral genes into the human genome. Med Hypotheses. 2018;110:50–2; DOI:10.1016/j.mehy.2017.10.023.
  2. 2. Chandler PA. Atrophy of the stroma of the iris. Am J Ophthalmol. 1956;41(4):607–15.10.1016/0002-9394(56)91655-5
  3. 3. Eagle RC, Font RL, Yanoff M, Fine BS. Proliferative endotheliopathy with iris bbnormalities. The iridocorneal endothelial syndrome. Arch Ophthalmol. 1979;97(11):2104-11; DOI:10.1001/archopht.1979.01020020422002.
  4. 4. Laganowski HC. Glaucoma and the iridocorneal endothelial syndrome. Arch Ophthalmol. 1992;110(3):346-50; DOI:10.1001/archopht.1992.01080150044025.
  5. 5. Shields MB. Progressive essential iris atrophy, Chandler’s syndrome, and the iris nevus (Cogan-Reese) syndrome: a spectrum of disease. Surv Ophthalmol. 1979;24(1):3–20; DOI:10.1016/0039-6257(79)90143-7.
  6. 6. Sacchetti M, Mantelli F, Marenco M, Macchi I, Ambrosio O, Rama P. Diagnosis and management of iridocorneal endothelial syndrome. BioMed Res Int. 2015;2015: 763093; DOI:10.1155/2015/763093.458835026451377
  7. 7. Silva L, Najafi A, Suwan Y, Teekhasaenee C, Ritch R. The iridocor-neal endothelial syndrome. Surv Ophthalmol. 2018;63(5):665–76; DOI:10.1016/j.survophthal.2018.01.001.29331589
  8. 8. Shields MB, Campbell DG, Simmons RJ, Hutchinson BT. Iris nodules in essential iris atrophy. Arch Ophthalmol. 1976;94(3):406–10; DOI:10.1001/archopht.1976.03910030194004.818989
  9. 9. Laganowski HC, Sherrard ES, Muir MG, Buckley RJ. Distinguishing features of the iridocorneal endothelial syndrome and posterior polymorphous dystrophy: the value of endothelial specular microscopy. Br J Ophthalmol. 1991;75(4):212–6; DOI:10.1136/bjo.75.4.212.10423232021586
  10. 10. Teekhasaenee C. Iridocorneal Endothelial syndrome in Thai patients: clinical variations. Arch Ophthalmol. 2000;118(2):187-92; DOI:10.1001/archopht.118.2.187.10676783
  11. 11. Hirst LW, Quigley HA, Stark WJ, Shields MB. Specular microscopy of iridocorneal endothelial syndrome. Am J Ophthalmol. 1980;89(1):11–21; DOI:10.1016/0002-9394(80)90223-8.
  12. 12. Sherrard ES, Frangoulis MA, Muir MG, Buckley RJ. The posterior surface of the cornea in the iridocorneal endothelial syndrome: a specular microscopical study. Trans Ophthalmol Soc UK. 1985;104(7):766–74.
  13. 13. Hirst LW, Quigley HA, Stark WJ, Shields MB. Specular microscopy of iridocorneal endothelia syndrome. Am J Ophthalmol. 1980;89(1):11–21; DOI:10.1016/0002-9394(80)90223-8.
  14. 14. Sherrard ES, Frangoulis MA, Muir MG. On the morphology of cells of posterior cornea in the iridocorneal endothelial syndrome. Cornea. 1991;10(3):233–243; DOI: 10.1097/00003226-199105000-00009.
  15. 15. Chiou AGY, Kaufman SC, Beuerman RW, Ohta T, Yaylali V, Kaufman HE. Confocal microscopy in the iridocorneal endothelial syndrome. Br J Ophthalmol. 1999;83(6):697–702.10.1136/bjo.83.6.697
  16. 16. Fayol N, Labbé A, Dupont-Monod S, Dupas B, Baudouin C. Apport de la microscopie confocale in vivo et de la tomographie en cohérence optique de chambre antérieure pour l’étude des pathologies endothéliales cornéennes. J Fr Ophtalmol. 2007;30(4):348–56; DOI:10.1016/S0181-5512(04)96276-6
  17. 17. Shields MB, Campbell DG, Simmons RJ. The essential iris atrophies. Am J Ophthalmol. 1978;85(6):749–59; DOI:10.1016/s0002-9394(14)78101-2.
  18. 18. De Maria M, Iannetta D, Moramarco A, Fontana L. Iridocorneal endothelial syndrome in a patient with keratoconus – a case report. BMC Ophthalmol. 2019;19(1):221; DOI:10.1186/s12886-019-1215-x.
  19. 19. Kidd M, Hetherington J, Magee S. Surgical results in iridocorneal endothelial syndrome. Arch Ophthalmol. 1988;106(2):199–201; DOI:10.1001/archopht.1988.01060130209027.
  20. 20. Lanzl IM, Wilson RP, Dudley D, Augsburger JJ, Aslanides IM, Spaeth GL. The outcome of trabeculectomy with mitomycin-C in the iridocorneal endothelial syndrome. Ophthalmology. 2000;107(2):295–7; DOI:10.1016/s0161-6420(99)00077-9.
  21. 21. Chandran P, Rao HL, Mandal AK, Choudhari NS, Garudadri CS, Senthil S. Outcomes of primary trabeculectomy with mitomycin-C in glaucoma secondary to iridocorneal endothelial syndrome. J Glaucoma. 2016;25(7):e652–6. DOI:10.1097/IJG.0000000000000268.25943731
  22. 22. Rodrigo-Rey S, Bolí var G, Paz J, Teus MÁ. Ex-PRESS® implant as the first surgical option in the iridocorneal endothelial syndrome. Arch Soc Esp Oftalmol (Engl Ed). 2021;96(8):430–3; DOI:10.1016/j.oftale.2020.12.006.34340781
  23. 23. Lin MM, Morgan WH, Kolomeyer NN, Moster SJ, Zheng CX, Giubilato A, Moster MR. XEN gel stent to treat ICE syndrome: 4 cases. J Glaucoma. 2019;28(12):1090-4; DOI:10.1097/IJG.0000000000001341.688886831425336
Language: English
Page range: 56 - 60
Submitted on: Apr 24, 2022
|
Accepted on: Jun 15, 2022
|
Published on: Jul 9, 2022
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2022 Aleksandra Krasińska, Joanna Mamczur, Manuela Pajdowska, Agata Brązert, published by Foundation for Cell Biology and Molecular Biology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.